FGFR4 and ovarian carcinoma: In a study of ovarian cancer, FGFR4 was shown to be a prognostic indicator in advanced-stage disease, and inhibition of FGFR4 with siRNA significantly inhibited ovarian tumor growth in vivo and in vitro [8].